The survival curves were not able to segregate MPN with a CMML-like phenotype from CMML, regardless if JAK2-mutated or nonmutated, but the survival of both groups was clearly different fromPV patients without monocytosis. The gene discussed is JAK2; the disease is chronic myelomonocytic leukemia.